Get started
Author

William O. Haston

Observed names: W. O. Haston, William Haston, William O Haston
OpenAlex ID: A5032028620
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2
2005 · Ronald Esser, Carol Berry, et al. · British Journal of Pharmacology · 124
Novel C5a Receptor Antagonists Regulate Neutrophil Functions In Vitro and In Vivo
1998 · Theodore C Pellas, William Boyar, et al. · The Journal of Immunology · 57
PDF
The pharmacophore of the human C5a anaphylatoxin
1994 · Matthew J. Toth, Leslie Huwyler, et al. · Protein Science · 36
PDF
Characterization of the binding of bolton-hunter labeled [125I]C5a to human neutrophil, monocyte and U-937 cell membranes
1992 · Albert F. Braunwalder, Donna Musmanno, et al. · Molecular Immunology · 14
Platelet activating factor stimulates intracellular calcium transients in human neutrophils: involvement of endogenous 5-lipoxygenase products
1992 · John J Rediske, Joe C Quintavalla, et al. · Journal of Leukocyte Biology · 13
Exposure of Human Vascular Smooth Muscle Cells to Raf-1 Antisense Oligodeoxynucleotides: Cellular Responses and Pharmacodynamic Implications
1998 · Christoph Schumacher, Catherine L. Cioffi, et al. · Molecular Pharmacology · 10
Fluorometer based multi-parameter analysis of phagocytic cell activation
1987 · B. Seligmann, K. Patel, et al. · Inflammation Research · 6
LTB4-induced transient neutropenia in the rat: A model for evaluating efficacy and bioavailability of LTB4 receptor antagonists
1993 · Theodore C. Pellas, Carmelo Colombo, et al. · Journal of Pharmacological and Toxicological Methods · 4
Works count: 8
Citation count: 264
H-index: 6
I10-index: 6
Year
Topic
Type